Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Adjuvant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05595408
What this trial is testing

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

Who this might be right for
Muscle Invasive Upper Tract Urothelial Carcinoma
RenJi Hospital 84
Not applicableUnknownNCT05362825
What this trial is testing

Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer

Who this might be right for
Liver Metastasis Colon CancerSynchronous Neoplasm
Cho Ray Hospital 89
Not applicableUnknownNCT03842176
What this trial is testing

Clinical Application of CTC in Operable Breast Cancer Patients

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 90
Large-scale testing (Phase 3)Active Not RecruitingNCT03576417
What this trial is testing

A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 680
Testing effectiveness (Phase 2)UnknownNCT01487226
What this trial is testing

Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer

Who this might be right for
Cervical Cancer
Korean Gynecologic Oncology Group 69
Testing effectiveness (Phase 2)Ended earlyNCT00036621
What this trial is testing

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

Who this might be right for
Breast Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT07537699
What this trial is testing

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

Who this might be right for
Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Testing effectiveness (Phase 2)UnknownNCT02461836
What this trial is testing

Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 513
Testing effectiveness (Phase 2)Active Not RecruitingNCT02124421
What this trial is testing

HOT: HIPEC in Ovarian Cancer as Initial Treatment

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian CancerEpithelial Ovarian Cancer+4 more
Mercy Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT01588704
What this trial is testing

Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma

Who this might be right for
Lung Cancer
Si-Yu Wang 42
Testing effectiveness (Phase 2)UnknownNCT05200299
What this trial is testing

MFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer

Who this might be right for
Colorectal Cancer
First Affiliated Hospital of Wenzhou Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07149363
What this trial is testing

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer (SCLC)
Alliance Foundation Trials, LLC. 65
Testing effectiveness (Phase 2)Looking for participantsNCT05726370
What this trial is testing

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerResectable Head and Neck Squamous Cell Carcinoma+2 more
Dana-Farber Cancer Institute 28
Testing effectiveness (Phase 2)Study completedNCT00003203
What this trial is testing

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma
Children's Oncology Group 168
Large-scale testing (Phase 3)Study completedNCT00129935
What this trial is testing

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 1,384
Not applicableStudy completedNCT01470404
What this trial is testing

Pharmacogenomic Study (Adjuvant Chemotherapy)

Who this might be right for
Gastric Cancer
Samsung Medical Center 792
Not applicableNot Yet RecruitingNCT07098949
What this trial is testing

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

Who this might be right for
Gastric Cancer
Guangzhou University of Traditional Chinese Medicine 346
Testing effectiveness (Phase 2)Ended earlyNCT00090844
What this trial is testing

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerHormone ChangesDrug Toxicity
University of South Florida 49
Large-scale testing (Phase 3)Active Not RecruitingNCT05180734
What this trial is testing

PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 878
Testing effectiveness (Phase 2)Looking for participantsNCT04768426
What this trial is testing

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerBreast Cancer
Stanford University 40
Next Page